CompletedNot Applicable

A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

United Kingdom68 participantsStarted 2022-08-03

Plain-language summary

Determine the baseline characteristics of patients who have recurrent symptomatic genital herpetic disease Determine the acceptance to patients of clinical trial procedures Determine interest in participation in genital herpes vaccine trials

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to understand and willing to sign the informed consent document. * Patient confirmation of a diagnosis of HSV-2 infection at least 2 years prior to inclusion. Laboratory confirmation is not required. * Symptomatic recurrent genital herpetic disease for \>2 years supported by compatible clinical history Exclusion Criteria: * Subjects who do not meet the inclusion criteria for the study * Subjects who are unable to provide legally effective informed consent

What they're measuring

Baseline characteristics of patients who have recurrent symptomatic genital herpetic disease

Timeframe: day of questionnaire

Acceptance to patients of clinical trial procedures

Timeframe: day of questionnaire

Interest in participation in genital herpes vaccine trials

Timeframe: day of questionnaire

Trial details

NCT IDNCT05500053

SponsorRational Vaccines Inc

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Genital Herpes trials